Evaluation of Tobacco Use and Her-2 Receptor Expression in Breast Cancer in an Ethnically Diverse Inner-City Population

Damien M. Hansra, Judith Hurley

Sylvester Comprehensive Cancer Center at the University of Miami, Miami, USA.

DOI: 10.4236/ojepi.2014.42014                

Abstract

Background: Tobacco is linked to most cancers however despite overwhelming biological plausibility and decades of epidemiological studies, no association has been established between tobacco and breast cancer. Although estrogen receptor status has been looked at as a variable there has been no evaluation of the role of Her-2 and smoking in breast cancer. Methods: Review of records from patients treated at the University of Miami/Jackson Memorial Hospital from 1998-2012. The incidence of smoking and Her-2 expression in1255 women was evaluated. Data was analyzed by age, race, ethnic group, menopausal status, tumor stage, and ER/PR/Her-2 receptor status. Results: 1255 charts were analyzed with 1094 having full information. Overall rate of Her-2 expression 18.1%. The rate of Her-2 expression was 21.4% in smokers and 17.0% in non-smokers (p = 0.10). The rate of Her-2 expression was 10.8% in Caucasian smokers and 9.8% in Caucasian non-smokers (p = 0.88); 24.5% in smokers of African descent and 17.3% in non-smokers of African descent (p = 0.24); 22.9% in Latino smokers and 17.4% in Latino non-smokers (p = 0.10). The rate of Her-2/ER expression was 9.4% in smokers and 7.9% in non-smokers (p = 0.42); 5.4% in Caucasian smokers and 4.9% in Caucasian non-smokers (p = 0.916); 12.2% in smokers of African descent and 5.9% in non-smokers of African descent (p = 0.11); 9.5% in Latin smokers and 8.8% in Latin non-smokers (p = 0.77). Conclusions: We found non-statistically significant positive associations in all analyses between Her-2 expression with or without ER expression and tobacco exposure when analyzed by ethnicity.

Keywords

HER-2, Breast Cancer, Tobacco

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Fiore, M.C., et al. (2000) Treating Tobacco Use and Dependence. US Department of Health and Human Services, Washington DC.
[2]	Terry, P.D. and Rohan, T.E. (2002) Cigarette Smoking and the Risk of Breast Cancer in Women: A Review of the Literature. Cancer Epidemiology, Biomarkers & Prevention, 11, 953-971.
[3]	Band, P.R., et al. (2002) Carcinogenic and Endocrine Disrupting Effects and Risk of Breast Cancer. The Lancet, 260, 1044-1049. http://dx.doi.org/10.1016/S0140-6736(02)11140-8
[4]	Yamasaki, E. and Ames, N.B. (1977) Concentration of Mutagens From Urine by Absorption with the Nonpolar Resin XAD-2: Cigarette Smokers Have Mutagenic Urine. Proceedings of the National Academy of Sciences of the United States of America, 74, 3555-3559. http://dx.doi.org/10.1073/pnas.74.8.3555
[5]	Plant, A.L., Benson, D.M., Smith, L.C. (1985) Cellular Uptake and Intracellular Localization of Benzo(a) Pyrene by Digital Fluorescence Imaging Microscopy. The Journal of Cell Biology, 100, 1295-1308. http://dx.doi.org/10.1083/jcb.100.4.1295
[6]	Shu, H.P. and Bymun, E.N. (1983) Systemic Excretion of Benzo(a) Pyrene in the Control and Microsomally Induced Rat: The Influence of Plasma Lipoproteins and Albumin as Carrier Molecules. Cancer Research, 43, 485-490.
[7]	Hech, S.S. (2002) Tobacco Smoke Carcinogens and Breast Cancer. Environmental and Molecular Mutagenesis, 39, 119-126. http://dx.doi.org/10.1002/em.10071
[8]	Morris, J.J. and Seifter, E. (1992) The Role of Aromatic Hydrocarbons in the Genesis of Breast Cancer. Medical Hypotheses, 38, 177-184. http://dx.doi.org/10.1016/0306-9877(92)90090-Y
[9]	Obana, H., Hori, S., Kashimoto, T. and Kunita, N. (1981) Polycyclic Aromatic Hydrocarbons in Human Fat and Liver. Bulletin of Environmental Contamination and Toxicology, 27, 23-27.